Show MeNo, a standard drug test cannot directly tell whether a urine sample is old. Immunoassay and mass spectrometry screens detect drug compounds and their metabolites, not the age of the specimen. Age-related clues exist, but they are indirect, unreliable, and rarely used to date a sample. Only observed collection reliably establishes when urine was produced.
That answer sounds simple, but the underlying science is messier than most thin explainers admit. Labs can flag a sample as inconsistent, diluted, or adulterated. They can measure creatinine and specific gravity. None of those tests report "age" the way a timestamp would. Understanding why requires looking at what drug tests actually measure and what happens to urine as it sits.
What immunoassays actually bind
A screening immunoassay is an antibody-based test. The antibody is engineered to bind a specific molecular shape, such as the epitope on a morphine molecule or the structure of a benzoylecgonine metabolite (the primary cocaine breakdown product). When binding occurs, the assay produces a signal that a reader converts to a positive or negative result.
This mechanism explains the core limitation. The antibody recognizes chemistry, not chronology. A metabolite molecule in fresh urine has the same shape as the same molecule in week-old urine. The antibody has no way to ask when the molecule arrived. There is no "freshness receptor."
Most workplace and clinical screens use competitive immunoassays with cutoff concentrations. A sample is called positive when the signal crosses a threshold, typically in nanograms per milliliter. The cutoff is a concentration decision, not an age decision. A 2019 review of urine drug testing in clinical settings described these assays as designed for presence and concentration, with no age-discrimination capability by design.
Confirmatory testing uses gas or liquid chromatography coupled to mass spectrometry. These instruments separate molecules by physical properties and identify them by mass-to-charge ratios. They are far more specific than immunoassays, but specificity is still chemical. A mass spectrometer reports what a molecule is and how much is present. It does not report when the molecule was deposited.
Plain language: drug tests are molecular detectors, not timestamps.
What "old" actually does to a sample
Urine is a biologically active liquid even after collection. Bacteria, enzymes, and dissolved gases keep working. What changes over time depends on storage conditions more than elapsed hours.
Bacterial growth is the dominant process at room temperature. Urease-producing organisms split urea into ammonia and carbon dioxide, raising pH. As pH climbs, some drugs degrade faster. Cocaine and its metabolites are especially vulnerable to alkaline hydrolysis, meaning they break apart chemically in basic conditions. A sample left warm for days can lose measurable cocaine signal even though the drug was genuinely present at collection.
Evaporation is the second process. An unsealed container loses water, concentrating everything dissolved in it. Specific gravity and creatinine rise. A concentrated old sample can look like a fresh, highly concentrated one on those measures alone.
Light and heat accelerate degradation of some analytes, including cannabinoids, though the effect varies by compound. Refrigeration slows bacterial growth and most degradation pathways. Freezing slows them further but can cause precipitation that complicates reanalysis.
The professional caveat: degradation is not a clock. Two samples stored identically for the same time can diverge because of bacterial load, pH, and initial composition. You cannot back-calculate collection time from analyte loss with any useful precision.
Quantified context for stability
Published stability data give ranges, not guarantees. General patterns from forensic and clinical toxicology guidance:
Cocaine and benzoylecgonine degrade measurably in unpreserved urine at room temperature within days, with alkaline pH accelerating loss. Cannabinoid metabolites are comparatively stable but can decline over weeks at room temperature. Opiates such as morphine and codeine are relatively stable, though conjugation and bacterial activity can shift results. Amphetamines are generally stable under refrigeration. Creatinine decreases as bacteria consume it, which is one reason it serves as a dilution marker rather than an age marker.
These are qualitative ranges from method-validation literature, not universal constants. The exact rate depends on matrix, concentration, and storage. Any claim of a precise "urine expires in X hours" figure should be treated as an approximation at best.
Timeline of specimen changes
| Timeframe | Storage condition | What typically changes |
|---|---|---|
| 0–24 hours | Room temperature, sealed | Minimal analyte loss; bacterial growth beginning |
| 1–3 days | Room temperature | pH may rise; creatinine begins declining; some cocaine loss |
| 3–7 days | Room temperature | Bacterial overgrowth likely; variable analyte degradation |
| 1–2 weeks | Room temperature | Substantial compositional drift; unreliable for reanalysis |
| Up to 1 week | Refrigerated (2–8 °C) | Slower change; most analytes largely preserved |
| Weeks to months | Frozen | Best preservation, but freeze-thaw cycles can alter matrix |
| Any | Unsealed, warm, light-exposed | Fastest degradation; concentrate effects from evaporation |
This table describes typical patterns, not certified limits. Labs set their own acceptance windows based on validation studies.
Edge cases that confound age judgments
Observed collection is the only reliable way to know when urine was produced. When collection is unobserved, several scenarios defeat any age inference.
Substituted urine is a known issue in forensic settings. A donor may present a sample collected earlier, or fluid that was never urine. Specimen validity testing can catch some substitutions through creatinine, pH, and specific gravity thresholds, but a well-matched substitute can pass. Validity testing answers "is this plausible human urine," not "when was it made."
Dilution and adulteration create their own confusion. A very dilute sample has low creatinine. A concentrated old sample has high creatinine from evaporation. The two can look similar on some panels if only one measure is considered. That is why validity testing uses multiple markers together.
Certain medical conditions change baseline values. Diabetes insipidus produces very dilute urine. Kidney disease alters creatinine. Someone with a urinary tract infection may have high bacterial load and altered pH at the moment of collection. These states mimic "old" or "altered" samples without any storage delay.
Counterintuitive detail: a fresh sample can fail validity checks and an old sample can pass them. Freshness and validity are not the same property.
Misconceptions worth correcting
The most common misconception is that labs routinely "age" samples. They do not, because the measurement does not exist in any validated form. Validity testing is the closest thing, and it assesses plausibility, not chronology.
Another misconception is that refrigeration "resets" a sample. Cold storage slows change; it does not reverse it. A degraded analyte stays degraded.
A third is that a positive result proves recent use. Detection windows depend on dose, metabolism, hydration, and cutoff. Chronic cannabis users can test positive for weeks after last use, far longer than occasional users. The result indicates exposure within a window, not timing within that window.
A fourth is that old urine is always invalid. It may be perfectly valid for some analytes and useless for others. Cocaine may be gone while opiates remain detectable. A single "invalid" label can hide analyte-specific differences.
Practical actions and thresholds
If you need to know whether a sample is fresh, the reliable method is observed collection with chain-of-custody documentation. That is a procedural control, not a lab test.
For specimen validity, labs commonly apply thresholds such as creatinine below 20 mg/dL suggesting dilution, and specific gravity outside roughly 1.003 to 1.030 suggesting abnormality. pH outside about 4.5 to 8.0 raises flags. These thresholds are reconciled across guidelines: a single abnormal value is often repeated or confirmed before an integrity finding. No threshold combination dates the sample.
Storage guidance for anyone handling specimens:
Refrigerate at 2–8 °C if analysis is delayed beyond a day. Seal containers to limit evaporation and contamination. Record collection time and storage conditions on the chain-of-custody form. Avoid repeated freeze-thaw cycles. Do not rely on appearance, color, or odor to judge age.
Red flags that a sample's history is uncertain:
Unobserved collection with no documentation. Creatinine and specific gravity that disagree in direction. pH outside the expected range without a medical explanation. Volume or container inconsistent with the collection record. Discrepancy between screening and confirmation results.
Limits of what can be concluded
The honest position is that urine age is not a measurable property with current forensic tools. Labs can describe composition, flag implausibility, and confirm identity of analytes. They cannot certify when the fluid left the body.
This matters for legal and workplace contexts. A positive result supports exposure within a detection window. An invalid result supports a specimen integrity concern. Neither supports a statement about sample age. Arguments that rely on age inference should be treated as speculative unless collection was directly observed.
Cost and access vary, so specific prices and turnaround times are deliberately omitted here. The stable conclusion is the one that survives scrutiny: drug tests detect molecules, and molecules do not carry timestamps.